Impact of low skeletal muscle mass and quality on clinical outcomes in patients with head and neck cancer undergoing (chemo)radiation
Lilia Bardoscia, Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia), Salvatore Cozzi(Azienda Sanitaria Unità Locale di Reggio Emilia), Pierpaolo Pattacini(Azienda Sanitaria Unità Locale di Reggio Emilia), Massimo Roncali(Azienda Sanitaria Unità Locale di Reggio Emilia), Luca Braglia(University of Modena and Reggio Emilia), Carmine Pinto(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Candida Bonelli, Efrem Bonelli(Azienda Sanitaria Unità Locale di Reggio Emilia), Giulia Besutti(University of Modena and Reggio Emilia), Maria E. Pagano(Siemens Healthcare (United States)), Massimo Pellegrini(University of Modena and Reggio Emilia), Cinzia Iotti(Azienda Sanitaria Unità Locale di Reggio Emilia)
Cited by 17
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
|Journal of Clinical Oncology|2011|763
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study
|Modern Pathology|2015|317
Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial
|Lung Cancer|2009|277
Stereotactic body radiation therapy for lung metastases
|Lung Cancer|2011|146